Anzeige
Mehr »
Login
Samstag, 11.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Innocan Pharma News: Unfassbare Studie - LPT-Therapie bewahrt Patient vor dem Tod!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
396 Leser
Artikel bewerten:
(1)

Corbion first half 2019 results

Corbion reported H1 2019 sales of € 471.9 million, an increase of 7.4% compared to H1 2018, mostly because of positive currency effects. Organic sales growth was 0.9%. Adjusted EBITDA in H1 2019 decreased by 0.1% to € 71.4 million due to 0.6% organic growth, positive currency effects, more than offset by a negative impact of the consolidation of the acquired Algae Ingredients plant in Brazil.

"In the first half I was pleased to see a continued acceleration in the organic sales growth rates for our important Food business segment. Ingredient Solutions showed a mixed performance and ended below the targeted sales growth bandwidth as the Biochemicals business segment was facing significant headwinds in Electronics and Agrochemicals. Our EBITDA margins remained at a healthy level in both Food and Biochemicals. In Innovation Platforms we continued on our growth trajectory in the first half. The Total Corbion PLA joint venture saw a very strong performance in H1 2019, supported by positive market developments.

I would like to thank everybody for their support in the past 5 years. It has been my privilege to have served as Corbion's CEO. As I step down, I will be handing over to Olivier Rigaud. I would like to wish Olivier and all Corbion colleagues all the best in taking the business forward", said Tjerk de Ruiter, CEO.

Key financial highlights first half of 2019

  • Net sales organic growth was 0.9%; volume growth was 1.8%
  • Adjusted EBITDA was € 71.4 million (H1 2018: € 71.5 million), an organic increase of 0.6% (including 5.3% positive effect from IFRS 16 implementation)
  • Adjusted EBITDA margin was 15.1% (H1 2018: 16.3%)
  • Adjustments at EBITDA level of € +3.4 million
  • Operating result was € 46.4 million (H1 2018: 50.2 million)
  • Free cash flow was € -29.3 million (H1 2018: €-16.3 million); the decline is mostly due to the acquisition of Granotec do Brazil (25 April 2019)
  • Net debt/EBITDA at half-year end was 2.1x (year-end 2018: 1.8x)
€ millionYTD 2019YTD 2018Total growthOrganic growth
Net sales471.9 439.2 7.4%0.9%
Adjusted EBITDA71.4 71.5 -0.1%0.6%
Adjusted EBITDA margin 15.1%16.3%
Operating result46.4 50.2 -7.6%0.8%
ROCE10.0%14.9%

Attachment

  • 20190807 1H19 Corbion press release ENG (https://ml-eu.globenewswire.com/Resource/Download/efbf156c-25ca-47df-b181-eabcd4c60720)
Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2019 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.